Company profile

Ticker
AGN
Exchange
CEO
Brenton L. Saunders
Employees
Incorporated
Location
Fiscal year end
Former names
Actavis Ltd, Actavis plc
SEC CIK

AGN stock data

(
)

Calendar

7 May 20
25 Sep 20
31 Dec 20

News

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 16,532 0 0
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 9,538 0 16,542
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 471 0 26,080
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No 70.79 9,446 668.68K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No 73.14 3,691 269.96K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No 90.22 2,790 251.71K 0
8 May 20 William Meury RSU Sale back to company Dispose D No 0 25,201 0 0
8 May 20 William Meury Ordinary Shares, par value $0.0001 Sale back to company Dispose D No 0 7,434 0 0
8 May 20 William Meury Performance Stock Units Ordinary Shares Sale back to company Dispose D No 0 26,506 0 0
8 May 20 William Meury Stock Options Ordinary Shares Sale back to company Dispose D No 196.16 12,304 2.41M 0
0.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 9 854 -98.9%
Opened positions 1 79 -98.7%
Closed positions 846 154 +449.4%
Increased positions 2 277 -99.3%
Reduced positions 3 363 -99.2%
13F shares
Current Prev Q Change
Total value 22.42M 51.35B -100.0%
Total shares 272.23K 290M -99.9%
Total puts 0 5.74M EXIT
Total calls 0 1.18M EXIT
Total put/call ratio 4.9
Largest owners
Shares Value Change
Ashburton 195.5K $15.12M +12968.4%
JDC-JSC 35.07K $85K +615.7%
Cerebellum GP 20.26K $3.31M NEW
Advisor Partners 9.28K $1.64M 0.0%
Everence Capital Management 7.1K $1.37M 0.0%
Barings 4.87K $862K 0.0%
Valeo Financial Advisors 145 $28K -95.1%
Orion Portfolio Solutions 4 $1K -99.6%
IFP Advisors 0 $0 EXIT
Largest transactions
Shares Bought/sold Change
Vanguard 0 -25.15M EXIT
BLK BlackRock 0 -21.14M EXIT
STT State Street 0 -13.7M EXIT
CS Credit Suisse 0 -10.73M EXIT
Adage Capital Partners GP, L.L.C. 0 -9.37M EXIT
Farallon Capital Management 0 -9.3M EXIT
BAC Bank of America 0 -8.43M EXIT
C Citigroup 0 -7.93M EXIT
GS Goldman Sachs 0 -7.49M EXIT
Renaissance Technologies 0 -7.09M EXIT

Financial report summary

?
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: alpha, API, argument, Asia, AstraZeneca, autoimmune, behavior, biodegradable, broadest, built, buyer, Cadila, certainty, chain, composition, confirm, confirming, contamination, continent, Coolsculpting, CoolTone, Cream, cystic, declare, deliver, detailing, discontinuation, discontinued, distancing, Durysta, electronic, enrolling, environment, enzyme, Esthetique, evolve, exocrine, experienced, Gedeon, genericization, glaucoma, globe, half, home, hypertension, inability, indirectly, inhibitor, innovation, insufficiency, intracameral, intraocular, IOP, Ireland, Lab, Lazeo, LIBOR, lifetime, local, logistical, losing, medial, minute, mitigate, Nestle, OAG, ocular, OHT, outbreak, Pacific, pancreatic, pandemic, patient, pressure, rebate, recession, recovery, relationship, remotely, reply, Richter, satisfaction, Science, shelter, spent, spread, strain, susceptible, suspended, temporarily, Ubrelvy, unemployment, Viokace, Vital
Removed: absence, acceleration, acid, add, adjunctive, advancement, affirming, Akorn, Akron, Apotex, appellate, applied, Argentum, asserting, authorize, automatically, back, binding, BioMed, Biomedical, Body, bound, buy, calculate, calculated, capitalized, capitalizing, Center, centralized, certiorari, chosen, clarify, cloud, collateralization, collateralized, commonly, computing, concurrently, Contouring, contractually, conversion, correct, corrected, Corrupt, cumulative, delaying, Delzicol, denial, denying, Depressive, dermatology, determining, Deva, disgorgement, Disorder, dozen, Easement, enablement, enacted, enforceable, Envy, equaled, equipment, equitable, error, established, estate, Europe, exemption, exercised, expedient, explicitly, Famy, fiscal, fleet, fourth, Framework, gamma, GILTI, ground, Harbor, HD, higher, hosted, immunity, implementation, implicit, implicitly, improper, incorrectly, India, Influenced, InnoPharma, institute, instrument, intent, invalidity, inventorship, issuing, joinder, LA, land, lease, leasing, Legacy, legally, lessee, lessor, Lidoderm, LifeCell, limit, Low, mandatorily, mandatory, MDD, modified, modify, noncancelable, notification, offsetting, older, opening, option, orphan, ownership, package, pattern, Pennsylvania, pension, permission, pertaining, Pharmacal, pivotal, plant, Plastic, postretirement, practical, preferred, prepaid, preventing, privately, pronouncement, prospectively, purpose, qualify, Racketeer, rapastinel, rating, reaching, real, receptor, reclassification, reclassify, recognition, redeemed, refinancing, released, remove, renew, renewal, rental, Replacement, represented, requiring, residual, restitution, resurfacing, retinoic, retired, retrospective, retrospectively, revaluation, reversing, RORyt, ROU, SA, scaling, shortened, skin, Slayback, software, sovereign, standalone, statutory, stranded, substantive, substitute, Subtopic, suit, supplier, Surgery, suspension, Targeted, Taxed, TCJA, terminate, Therapy, threshold, topline, treble, tribal, TWi, Ubrogepant, unrelated, updated, USD, vendor, VI, Vitae, withdraw, withdrew, writ